Deceiving numbers: Survival rates and their impact on doctors' risk communication

Medical Decision Making

Volumn 31, Issue 3, 2011, Pages 386-394

  Wegwarth, Odette ^a   Gaissmaier, Wolfgang ^a   Gigerenzer, Gerd ^a  

^a MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

Author keywords

decision rules; health literacy; numeracy; risk communication or risk perception; shared decision making

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL COMPETENCE; DISEASE COURSE; DOCTOR PATIENT RELATION; EARLY DIAGNOSIS; FEMALE; GERMANY; HUMAN; INCIDENCE; INTERPERSONAL COMMUNICATION; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NEOPLASM; PROGNOSIS; QUESTIONNAIRE; RISK; RISK ASSESSMENT; STATISTICS; SURVIVAL RATE;

ADULT; AGED; CLINICAL COMPETENCE; COMMUNICATION; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PHYSICIAN-PATIENT RELATIONS; PROGNOSIS; QUESTIONNAIRES; RISK; RISK ASSESSMENT; SURVIVAL RATE; TRUTH DISCLOSURE;

EID: 79957623809     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X10391469     Document Type: Article

References (16)

1. Charles CA, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or, It takes at least two to tango). Soc Sci Med. 1997;44:681-92.
2. Mühlhauser I, Kasper J, Meyer G. FEND: understanding of diabetes prevention studies: questionnaire survey of professionals in diabetes care. Diabetologia. 2006;49:1742-6. (Pubitemid 44025027)
3. Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S. Helping doctors and patients to make sense of health statistics. Psychol Sci Public Interest. 2007;8:53-96.
4. Covey J. A meta-analysis of the effects of presenting treatment benefits in different formats. Med Decis Making. 2007;27:638-54. (Pubitemid 47547599)
5. Ghosh AK, Ghosh K. Translating evidence-based information into effective risk communication: current challenges and opportunities. J Lab Clin Med. 2005;145:171-80. (Pubitemid 40692399)
6. Fahey T, Griffiths S, Peters TJ. Evidence based purchasing: understanding results of clinical trials and systematic reviews. Br Med J. 1995;311:1056-9.
7. Naylor CD, Chen E, Strauss B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med. 1992;117:916-21.
8. Hembroff LA, Holmes-Rovner M, Wills CE. Treatment decision-making and the form of risk communication: results of a factorial survey. BMC Med Inform Decis Mak. 2004;4:20.
9. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA. 2000;283:2975-8.
10. Gordis L. Epidemiology. 4th ed. Philadelphia: Saunders; 2008.
11. Extramural Committee to Assess Measures of Progress Against Cancer. Measurement of progress against cancer. J Natl Cancer Inst. 1990;82:825-35.
12. Henschke C, International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763-71. (Pubitemid 44631359)
13. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003 (National Cancer Institute). 2005 [updated 2005; cited March 26, 2008]; Available from: URL: SEER Web site: http://seer.cancer.gov/csr/1975-2003/
14. Andriole GL, Crawford ED, Grubb RL III, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310-9.
15. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320-8.
16. Steurer J, Held U, Schmidt M, Gigerenzer G, Tag B, Bachman LM. Legal concerns trigger PSA testing. J Eval Clin Pract. 2009;15:390-2.